Totals represent the number of respondents who answered this question in the affirmative and the percentages indicate the proportion of the specific population who reported those consequences.
BackgroundThis study aims to assess the adverse events (AEs) and safety profile of omeprazole, a widely used proton pump inhibitor (PPI) for acid-related diseases. Despite being a first-line treatment
